Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Tirzepatide Safety Warning; Nurse Charged Over Fake GLP-1s; Revised Afrezza Dosing

Summary by MedPage Today
(MedPage Today) -- Tirzepatide (Mounjaro, Zepbound) users should never share KwikPens due to risk for transmission of blood-borne pathogens, the FDA warned in an updated label. GLP-1 medications for weight loss accounted for more than 7% of all...

2 Articles

MedPage TodayMedPage Today
Reposted by
Anti-Aging, Acupuncture and Health NewsAnti-Aging, Acupuncture and Health News
Center

Tirzepatide Safety Warning; Nurse Charged Over Fake GLP-1s; Revised Afrezza Dosing

(MedPage Today) -- Tirzepatide (Mounjaro, Zepbound) users should never share KwikPens due to risk for transmission of blood-borne pathogens, the FDA warned in an updated label. GLP-1 medications for weight loss accounted for more than 7% of all...

·New York, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MedPage Today broke the news in New York, United States on Tuesday, January 27, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

GLP-1 icon

GLP-1

United States icon

United States

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal